ancer broncho-s; Traitement; Localement avancé et inopérable; pulmonaire non à petites cellule
Abstract :
[fr] Le cancer broncho-pulmonaire non à petites cellules
(CBNPC) est fréquent. Pour près d’un patient sur cinq, au
moment du diagnostic, la maladie est déjà localement avancée
et inopérable. A ce stade, le pronostic de cette affection est
mauvais, caractérisé, entre autres, par un taux élevé de réci
-
dive locale, malgré la chimiothérapie et la radiothérapie. Le
but de cette revue est de décrire l’hétérogénéité de ce groupe
de patients, de clarifier les modalités de traitement combinant
la chimiothérapie et la radiothérapie et de préciser l’intérêt
des techniques modernes de radiothérapie pour améliorer le
contrôle local
Disciplines :
Oncology
Author, co-author :
BARTHELEMY, Nicole ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie
LENNERTS, Evelyne ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie
MEYNS, Mia ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie
DUYSINX, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
PAULUS, Astrid ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
COMPERE, C
BOSQUEE, Léon
JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
COUCKE, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie
Language :
French
Title :
LE DÉFI DU CONTRÔLE LOCAL DANS LE CANCER PULMONAIRE NON A PETITES CELLULES, LOCALEMENT AVANCE, NON OPERABLE
Publication date :
2014
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Alberg A J, Brock MV, Ford JG, et al. - Epidemiology of lung cancer : diagnosis and management of lung cancer, 3rd ed. American College of chest physicians Evidence-Based clinical practice guidelines. Chest, 2013, 143, e1S-e29S.
Bosetti C, Malvezzi M, Ross T, et al. - Lung cancer mortality in European women : trends and predictions. Lung Cancer, 2012, 78, 171-178.
Goldstraw P, Crowley J, Chansky K et al. - The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol, 2007, 2, 706-714. (Pubitemid 47357522)
Siegel R, Naishadham D, Jemal A. - Cancer statistics. CA Cancer J Clin, 2012, 62, 10-29.
Groome PA, Bolejack V, Crowley JJ. - The IASLC Lung Cancer Staging Project : validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol, 2007, 2, 694-705. (Pubitemid 47357521)
Detterbeck FC, Jantz MA, Wallace M, et al. - Invasive mediastinal staging of lung cancer : ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 2007, 132, 202S-220S. (Pubitemid 47502808)
Crino L, Weder W, van Meerbeeck J, et al. - Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2010, 21, v103-115.
Paez JG, Janne PA, Lee JC, et al. - EGFR mutations in lung cancer : correlation with clinical response to gefitinib therapy. Science, 2004, 304, 1497-1500. (Pubitemid 38720929)
Rothschild S, Zippelius A, Betticher DC, et al. - Nouveaux concepts thérapeutiques dans le cancer bronchique. Mécanismes oncogènes et marqueurs moléculaires. Forum Med Suisse, 2011,11, 941-947.
Antoun S, Baracos V. - Malnutrition in cancer patient: when to have a specialized consultation? Bull Cancer, 2009, 96, 615-623.
Bradley JD, Paulus R, Komaki R, et al. - A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer : results on radiation dose in RTOG 0617. J Clin Oncol, 2013, 31, 7501.
NSCLCCG. - Chemotherapy in non-small cell lung cancer : a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ, 1995, 311, 899-909.
Auperin A, Le Pechoux C, Pignon JP, et al. - Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC) : a meta-analysis of individual data from 1764 patients. Ann Oncol, 2006, 17, 473-483. (Pubitemid 43329586)
Aupérin A, Le Pechoux C, Rolland E, et al. - Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol, 2010, 28, 2181-2190.
Mornex F, Peignaux K, Germain T, et al. - Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancer. Lung Cancer, 2013, 80, 68-74.
Fletcher GH. - Clinical dose-response curves of human malignant epithelial tumours. Br J Radiol, 1973, 46, 1-12.
Dosoretz DE, Galmarini D, Rubenstein JH, et al. - Local control in medically inoperable lung cancer : an analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys, 1993, 27, 507-516. (Pubitemid 23331115)
Perez CA, Pajak TF, Rubin P, et al. - Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer, 1987, 59, 1874-1881. (Pubitemid 17072411)
Machtay M, Paulus R, Moughan J, et al. - Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. J Thorac Oncol, 2012, 7, 716-722.
Grills IS, Yan D, Black QC, et al. - Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2007, 67, 709-719. (Pubitemid 46215884)
Yuan S, Sun X, Li M, et al. - A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol, 2007, 30, 239-244. (Pubitemid 46884142)
Salama JK, Vokes EE. - New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer. J Clin Oncol, 2013, 31, 1029-1038.
Fenwick JD, Nahum AE, Malik ZI, et al. - Escalation and intensification of radiotherapy for stage III non-small cell lung cancer : opportunities for treatment improvement. Clin Oncol (R Coll Radiol), 2009, 21, 343-360.
O'Rourke N, Roque IFM, Farre Bernado N, et al. - Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev, 2010, 6, CD002140.
van Baardwijk A, Reymen B, Wanders, S, et al. - Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer. Eur J Cancer, 2012, 48, 2339-2346.
